跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
2F-7
首页
药物
2F-7
2F-7
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
SILVER COMPLEX FLUORIDE {BIS (1,3,5-TRIAZA-7-PHOSPHAADAMANTANE) SILVER FLUORIDE} - A NEW THERAPEUTIC AGENT FOR CARIES MANAGEMENT
US 20250129109 A1
申请人: UNIV HONG KONG
优先权: 2021
CN
US
2 件公开
Sequences of hepatitis C virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
US 6974864 B2
申请人: INNOGENETICS NV
优先权: 2001
US
2 件公开
16-Hydroxyestratrienes as selective estrogens
EP 1580192 A2
申请人: SCHERING AG
优先权: 1999
EP
4-(N-Phenylamino)-quinazolines/quinolines as inhibitors of tyrosine kinases
EP 2298305 A1
申请人: BOEHRINGER INGELHEIM PHARMA
优先权: 2003
EP
Fused pyrido¬3',2':4,5 thieno¬3,2-d pyrimidines and pyrido¬3',2':4,5 furo¬3,2-d pyrimidines
EP 1623987 A1
申请人: CURACYTE DISCOVERY GMBH
优先权: 2004
EP
3-Amino-6-aryl(or 6-heteroaryl)-4-R²-thieno[2,3-b]pyridin-2-carboxylic acid amides, pharmaceutical compositions comprising the said and their use as inhibitors of TNFalpha release
EP 1683799 A1
申请人: IBFB PHARMA GMBH
优先权: 2005
EP
Octahydro-pyrrolo[3,4-b]pyrrole derivatives
CN 101415709 A
申请人: ABBOTT LAB
优先权: 2006
CN
Pyridon carboxamides, agents containing these but not impacting useful plants and method for their manufacture and application
EP 1987717 A1
申请人: BAYER CROPSCIENCE AG
优先权: 2007
EP
Medicine for reducing vascular restenosis after sacculus injuries and rat model construction method
CN 109771412 A
申请人: UNIV ZUNYI MEDICAL
优先权: 2018
CN
基于吲哚-3-羧酸制备得到可促进寄生植物种子萌发的化合物及其制备方法
CN 113072544 B
申请人: 浙江农林大学
优先权: 2021
CN
第 1 / 2 页
上一页
下一页
药物
反馈